Verastem, Inc.
Verastem, Inc. (FWB: 2VSA) is trading at €6.72, about ₹731 at today's EUR/INR rate, as of 30 Sep 2026, 9:25 AM ET, up 0.09% today. Indian residents can buy Verastem from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€6.58
Today's high
€6.72
52 week low
€2.88
52 week high
€9.25
2VSA opened at €6.58, closed previously at €6.71, and has traded between €2.88 and €9.25 over the past 52 weeks.
About
Verastem, Inc. is a biopharmaceutical firm in its development phase, concentrating on the advancement and market introduction of therapeutic agents for oncological conditions. A primary investigational compound is VS-6766 (also known as avutometinib). This agent functions as a RAF/MEK clamp, impeding MEK kinase activity and the capacity of RAF to phosphorylate MEK. Its pipeline includes RAMP 201, an adaptive, two-part, multicenter, parallel cohort, randomized, open-label clinical trial. This study assesses the effectiveness and safety of avutometinib, both as a standalone treatment and in conjunction with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK), for individuals with recurrent low-grade serous ovarian cancer. Furthermore, RAMP 202 is a Phase 2 investigation exploring the safety of VS-6766 when co-administered with defactinib in patients diagnosed with KRAS and BRAF mutant non-small cell lung cancer, particularly after they have undergone platinum-based therapy and immune checkpoint inhibition. The company holds significant licensing agreements: one with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and production of products containing avutometinib, and another with Pfizer Inc. granting rights to research, develop, manufacture, and commercialize therapeutic, diagnostic, and prophylactic human applications utilizing Pfizer's FAK inhibitors. Verastem has also forged strategic collaborations. A clinical partnership with Amgen, Inc. involves the RAMP 203 Phase 1/2 trial, which is evaluating avutometinib in combination with Amgen's KRAS-G12C inhibitor, LUMAKRASTM. Additionally, a discovery and development partnership with GenFleet Therapeutics is focused on advancing novel programs aimed at cancers driven by the RAS pathway. Verastem, Inc., founded in 2010, has its corporate headquarters situated in Needham, Massachusetts.
Key statistics
Avg. volume
477.00
Market cap
€590.16M
P/E Ratio
-3.27
Price-to-sales ratio
8.08
Enterprise value
$427.62M
Free cash flow yield
-26.97%
Debt-to-equity ratio
1.69
Return on equity
-366.23%
ROIC
-94.51%
Beta
0.29
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
$30.92M
Earnings per share
-$3.02
Free cash flow
-$147.13M
Net profit margin
-231.59%
Gross margin
86.69%
EBITDA
-$169.41M
Revenue growth
209.16%
Similar securities
This is not an investment recommendation
How to buy Verastem from India
Indian residents can buy Verastem shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Verastem and place an order
Find Verastem by name or by its ticker, 2VSA, and choose an order type. Verastem trades 11:30 am – 11:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Verastem position in EUR and INR. Verastem pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Verastem from India
Trading and taxes when buying Verastem from India
Trading and limits
- Trading hours
- 8:00 am – 8:00 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneVerastem does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Verastem stock?
Yes. Verastem (2VSA) has been listed on the Frankfurt Stock Exchange since 2012, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Verastem share cost in rupees?
One Verastem share is €6.72 — about ₹731 at an EUR/INR rate of 108.91 on 29 Sep 2026. Both the Verastem price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Verastem from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Verastem shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Verastem price. Paasa issues a capital-gains statement for your return.
Does Verastem pay a dividend?
No. Verastem does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Verastem from India?
The Frankfurt Stock Exchange trades 11:30 am – 11:30 pm IST in Indian time. The window shifts to 12:30 pm – 12:30 am IST when Germany is on standard time. Orders can only execute during that window.
Is Verastem a Germany company, and does that change how it is taxed?
Verastem trades on the Frankfurt Stock Exchange in EUR, but the company is domiciled in United States. Verastem trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Verastem shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Verastem holding, its cost and its closing value.
How do I sell Verastem and bring the money back to India?
You sell during market hours (11:30 am – 11:30 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Verastem?
Yes. Verastem is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.